[1]
Khan, A.U.R. et al. 2025. CRISPR–Cas9 mediated repression of BACE1 for amyloid-beta reduction in early-stage Alzheimer’s disease: A meta-analysis . Pakistan Journal of Pathology. 36, 3 (Sep. 2025), 252–261. DOI:https://doi.org/10.55629/pakjpathol.v36i3.942.